10x Genomics Overview
10x Genomics Target Price
Analysts' 12-month price predictions for TXG.
Get informed when a big investor buys or sells
+ FollowShare Price
$32.16
Average Target Price
$22.29
30.7% downside
30.7% downside7 analysts in the last 4 months
High: $30 | Low: $17
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Morgan Stanley | $22 | 31.6% downside |  |
| 2026-04-14 | Barclays | $30 | 6.7% downside | |
| 2026-03-02 | Stifel NicolausDaniel Arias | $25 | 22.3% downside | |
| 2026-02-20 | UBS | $20 | 37.8% downside | |
| 2026-02-13 | Deutsche Bank | $17 | 47.1% downside | |
| 2026-02-13 | Stifel Nicolaus | $20 | 37.8% downside | |
| 2026-02-13 | Canaccord GenuityKyle Mikson | $22 | 31.6% downside | |
| 2026-01-12 | Needham | $21 | 34.7% downside | |
| 2025-12-22 | Canaccord Genuity | $20 | 37.8% downside | |
| 2025-12-15 | Barclays | $22 | 31.6% downside | |
| 2025-12-01 | Morgan StanleyKallum Titchmarsh | $20 | 37.8% downside | |
| 2025-08-11 | Canaccord GenuityKyle Mikson | $16 | 50.2% downside | |
| 2025-08-08 | UBSDan Leonard | $13 | 59.6% downside | |
| 2025-08-08 | Deutsche BankJustin Bowers | $14 | 56.5% downside | |
| 2024-08-13 | Morgan StanleyTejas Savant | $46 |  43% upside | |
| 2024-07-23 | Canaccord GenuityKyle Mikson | $32 | 0.5% downside | |
| 2024-07-10 | Deutsche BankJustin Bowers | $25 | 22.3% downside | |
| 2024-06-28 | BarclaysLuke Sergott | $24 | 25.4% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $24 | 25.4% downside | |
| 2024-05-01 | BarclaysLuke Sergott | $36 | 11.9% upside | |
| 2024-04-10 | BarclaysLuke Sergott | $45 | 39.9% upside | |
| 2022-12-14 | Deutsche Bank | $50 | 55.5% upside | |